Biotechnology Research
2-10 employees
Founded 2022
About Serinus Biosciences
Serinus Bio is revolutionizing drug development by harnessing the power of interactome foundation models to understand complex protein interactions. The company provides AI-powered platforms that accelerate drug discovery, disease pathway targeting, and the design of rational cancer combination therapies. Its primary customers are drug discovery firms, biotech companies, and clinical research organizations.
Company Classification
Customer Types
B2B
Business Models
ServicesLicensing
Product & Service Types
AI-powered drug discovery platformProtein interaction analysis softwareCombination therapy design tools
Funding
Total Funding
$500.0K
No. of Funding Rounds
1
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos